AC-262,536
From WikiProjectMed
(Redirected fromAC-262536)
Chemical compound
Pharmaceutical compound
![]() | |
Identifiers | |
---|---|
| |
CAS Number |
|
PubChemCID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C18H18N2O |
Molar mass | 278.355 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
AC-262536 is a drug developed byAcadia Pharmaceuticals which acts as aselective androgen receptor modulator (SARM). Chemically it possessesendo-exo isomerism, with the endo form being the active form. It acts as apartial agonist for theandrogen receptor with aKi of 5 nM, and no significant affinity for any other receptors tested. In animal studies it produced a maximal effect of around 66% of thelevator animuscle weight increase oftestosterone, but only around 27% of its maximal effect onprostate gland weight.[1][2][3] It is ananiline SARM related toACP-105 andvosilasarm (RAD140).[4]
References
- ^Piu F, Gardell LR, Son T, Schlienger N, Lund BW, Schiffer HH, Vanover KE, Davis RE, Olsson R, Bradley SR (March 2008). "Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator".J Steroid Biochem Mol Biol.109 (1–2):129–37.doi:10.1016/j.jsbmb.2007.11.001.PMID 18164613.S2CID 25172405.
- ^Cutler C, Viljanto M, Taylor P, Habershon-Butcher J, Muir T, Biddle S, Van Eenoo P (February 2021)."Equine metabolism of the selective androgen receptor modulator AC-262536 in vitro and in urine, plasma and hair following oral administration".Drug Testing and Analysis.13 (2):369–385.doi:10.1002/dta.2932.hdl:1854/LU-8694577.PMID 32959959.S2CID 221842707.
- ^Stacchini C, Botrè F, Comunità F, de la Torre X, Dima AP, Ricci M, Mazzarino M (February 2021). "Simultaneous detection of different chemical classes of selective androgen receptor modulators in urine by liquid chromatography-mass spectrometry-based techniques".Journal of Pharmaceutical and Biomedical Analysis.195: 113849.doi:10.1016/j.jpba.2020.113849.PMID 33383501.S2CID 229941017.
- ^Zhang X, Sui Z (February 2013). "Deciphering the selective androgen receptor modulators paradigm".Expert Opinion on Drug Discovery.8 (2):191–218.doi:10.1517/17460441.2013.741582.PMID 23231475.S2CID 2584722.
![]() | Thispharmacology-related article is astub. You can help Wikipedia byexpanding it. |
Retrieved from "https://mdwiki.org/wiki/AC-262,536"
Categories:
- Articles with short description
- Short description matches Wikidata
- Short description is different from Wikidata
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs missing an ATC code
- Drugs with no legal status
- Abandoned drugs
- Naphthalenes
- Nitriles
- Secondary alcohols
- Selective androgen receptor modulators
- Tropanes
- All stub articles
- Pharmacology stubs